As the deadlines for the US Drug Supply Chain Security Act (DSCSA) and the Falsified Medicines Directive (FMD) near, pharma businesses should be prioritising the validation of their solutions. Here, Lauren Catalano, Sharp Services, offers guidance Read more


The Association of the British Pharmaceutical Industry (ABPI) has responded to the recent publication of the Medicines and Healthcare products Regulatory Agency (MHRA) technical guidance on what the Brexit implementation means for life sciences. Read more


A new guide to help bioscience companies communicate R&D progress clearly and effectively to investors and the public has been released by the UK BioIndustry Association (BIA). Read more


A new paper from EEF is urging the government to set out clear guidance on the rules of engagement for industry sector deals ahead of the release of the Industrial Strategy White Paper, to minimise the impact of Brexit on supply chains. Read more